RPA1 and autoimmune disease: Conversely, blockade of T cell necroptosis by RIPK3 inhibitor largely ameliorated the inflammatory damage induced by RPA1 depletion, which further confirm the importance of T cell necroptosis in the pathogenesis of autoimmune disorders.